동물용 진단 시장 : 제품별, 동물 유형별, 기술별, 최종 사용자별, 지역별 분석 및 예측(-2032년)

According to Stratistics MRC, the Global Veterinary Diagnostics Market is accounted for $4.0 billion in 2025 and is expected to reach $7.4 billion by 2032 growing at a CAGR of 9.1% during the forecast period. The methods and equipment used to determine an animal's illness, condition, and general state of health are referred to as veterinary diagnostics. It consists of imaging, molecular diagnostics, and laboratory testing that assist veterinarians in identifying infections, genetic abnormalities, and other health problems. In order to provide efficient treatment, illness prevention, and animal welfare, these diagnostics are essential. Veterinary diagnostics help livestock management and companion animal care by facilitating early and accurate diagnosis, which benefits food safety, public health, and the global animal healthcare sector.

According to the American Pet Products Association (APPA) study conducted between 2023 and 2024, approximately 66% of households in the U.S. have at least one pet, totaling around 86.9 million households.

Market Dynamics:

Driver:

Growth in pet ownership and expenditure

The amount spent on pets' health and wellbeing has increased as more homes consider them members of the family. The need for sophisticated diagnostic instruments to guarantee prompt and precise illness diagnosis is fuelled by this trend. More and more pet owners are prepared to spend money on routine examinations and preventive care. As a result, hospitals and veterinary clinics are implementing advanced diagnostic tools. The market for veterinary diagnostics is growing as a direct result of this increase in demand.

Restraint:

High cost of diagnostic equipment

Advanced diagnostic equipment is out of reach for many veterinary clinics, particularly those in rural or developing areas. This restricts their capacity to provide prompt and precise diagnosis. As a result, delayed or ineffective therapies negatively impact animal healthcare. Investment in contemporary diagnostic methods is sometimes deterred by high equipment prices. This slows down market growth, especially for small and mid-sized veterinary service providers.

Opportunity:

Telemedicine and remote diagnostics

Veterinarians can now consult, diagnose, and keep an eye on pets and livestock remotely thanks to this technology. Pet owners and farm managers save money and travel time as a result, increasing customer happiness and compliance. Mobile imaging equipment and wearable health monitors are examples of remote diagnostics technologies that offer real-time data for precise evaluations. Early disease detection and more frequent checkups are also encouraged by the effectiveness and convenience of telemedicine. Consequently, the need for instruments and diagnostic services specifically designed for virtual veterinarian care is increasing.

Threat:

Risk of zoonotic outbreak mismanagement

Ineffective handling of zoonotic outbreaks erodes confidence in veterinary healthcare systems and discourages diagnostic investment. Inadequate or delayed reactions may result in unchecked disease transmission, raising both human and animal mortality. Government and public trust in the current veterinary infrastructure is damaged as a result. Focus frequently shifts from preventive diagnosis to emergency response as a result of the ensuing panic and economic upheaval. Regulations may be put in place by regulatory agencies that hinder innovation and market growth. All things considered, ineffective outbreak management stunts expansion and reduces demand for cutting-edge veterinary diagnostics.

Covid-19 Impact

The COVID-19 pandemic disrupted the veterinary diagnostics market initially due to lockdowns, reduced veterinary visits, and supply chain issues. However, increased pet adoption and growing awareness of zoonotic diseases fueled demand for diagnostic testing. Telemedicine and point-of-care diagnostics gained traction, driving innovation in the sector. Research on animal health and disease surveillance intensified, highlighting the market's resilience. Overall, while the market faced early setbacks, it rebounded strongly, with long-term growth supported by heightened focus on animal health and public safety.

The instruments segment is expected to be the largest during the forecast period

The instruments segment is expected to account for the largest market share during the forecast period, due to accurate disease detection in animals. The efficiency and dependability of diagnosis have been greatly increased by technological developments in analysers and imaging equipment. These tools facilitate early diagnosis, allowing for prompt treatment and better results for the health of the animals. The usage of diagnostic tools is further fuelled by increased livestock production demands and pet ownership. The expansion of this market is also supported by more investments in the infrastructure of veterinary healthcare.

The urinalysis segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the urinalysis segment is predicted to witness the highest growth rate, due to by enabling early detection of various diseases and diabetes in animals. It improves the effectiveness of veterinary care by providing a quick, affordable, and non-invasive diagnostic technique. The need for routine urine testing is being driven by rising pet ownership and greater knowledge of animal health. Further streamlining diagnostic processes and increasing accuracy are technological developments in automated urine analysers. Because of this, urinalysis is essential to preventative healthcare and helps the veterinary diagnostics market as a whole.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising pet ownership, increasing awareness of animal health, and expanding livestock production. Advancements in diagnostic technologies, such as molecular diagnostics and biosensors, are enhancing disease detection and management. Governments are also strengthening animal health initiatives, boosting demand for timely diagnostics. Key countries like China, India, and Japan are driving market expansion, supported by growing veterinary infrastructure and investment from global animal health companies targeting this dynamic region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to rising awareness of animal health, and advancements in diagnostic technologies. The region benefits from well-established veterinary infrastructure, high healthcare expenditure on companion animals, and a growing demand for early disease detection. Key market players are investing in innovative diagnostic tools, including molecular diagnostics and point-of-care testing. The livestock sector also contributes to market expansion, with emphasis on disease control and food safety. The United States holds the largest market share in the region.

Key players in the market

Some of the key players profiled in the Veterinary Diagnostics Market include IDEXX Laboratories, Inc., Zoetis Services LLC, Heska Corporation, Thermo Fisher Scientific Inc., Avante Animal Health, Virbac, Randox Laboratories Ltd., VCA Animal Hospitals, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Antech Diagnostics, Inc., Agrolabo S.p.A., Embark Veterinary, Inc., Esaote SPA, Innovative Diagnostics SAS, FUJIFILM Corporation, Neogen Corporation, Bio-Rad Laboratories, Inc., INDICAL Bioscience GmbH

Key Developments:

In February 2024, IDEXX enhanced VetConnect PLUS(R), enabling veterinarians to access reference lab sample turnaround times and order status information. Additionally, IDEXX DecisionIQ(TM), integrated within VetConnect PLUS(R), provides AI-driven clinical decision support for conditions like vector-borne diseases, chronic kidney disease, and endocrine disorders.

In August 2023, Zoetis launched Vetscan Mastigram+, a rapid on-farm mastitis diagnostic tool in several European markets. This product enables farmers and veterinarians to detect Gram-positive mastitis in cows within 8 hours, facilitating targeted antimicrobial therapy.

In January 2023, IDEXX launched a new diagnostic test for kidney injury in cats and dogs, enhancing its renal testing portfolio. This innovation helps veterinarians detect kidney damage earlier, improving treatment outcomes and advancing IDEXX's commitment to providing comprehensive, accurate diagnostic solutions for veterinary care.

Products Covered:

• Instruments
• Consumables

Animal Types Covered:

• Companion Animals
• Production Animals

Technologies Covered:

• Immunodiagnostics
• Clinical Biochemistry
• Molecular Diagnostics
• Hematology
• Urinalysis
• Microbiology
• Other Technologies

End Users Covered:

• Veterinary Hospitals & Clinics
• Reference Laboratories
• In-House Testing
• Research Institutes & Universities
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.1 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Veterinary Diagnostics Market, By Product

• 5.1 Introduction
• 5.2 Instruments
  • 5.2.1 Hematology analyzers
  • 5.2.2 Biochemistry analyzers
  • 5.2.3 Immunodiagnostic analyzers
  • 5.2.4 Molecular diagnostic instruments
• 5.3 Consumables
  • 5.3.1 Reagents
  • 5.3.2 Test kits
  • 5.3.3 Panels
  • 5.3.4 Strips

6 Global Veterinary Diagnostics Market, By Animal Type

• 6.1 Introduction
• 6.2 Companion Animals
  • 6.2.1 Dogs
  • 6.2.2 Cats
  • 6.2.3 Horses
• 6.3 Production Animals
  • 6.3.1 Cattle
  • 6.3.2 Swine
  • 6.3.3 Poultry
  • 6.3.4 Sheep & Goats

7 Global Veterinary Diagnostics Market, By Technology

• 7.1 Introduction
• 7.2 Immunodiagnostics
  • 7.2.1 Enzyme-linked Immunosorbent Assay (ELISA)
  • 7.2.2 Lateral Flow Assays
  • 7.2.3 Rapid Tests
• 7.3 Clinical Biochemistry
  • 7.3.1 Glucose monitoring
  • 7.3.2 Electrolyte analysis
• 7.4 Molecular Diagnostics
  • 7.4.1 Polymerase Chain Reaction (PCR)
  • 7.4.2 Microarrays
  • 7.4.3 Nucleic Acid Sequencing
• 7.5 Hematology
• 7.6 Urinalysis
• 7.7 Microbiology
• 7.8 Other Technologies

8 Global Veterinary Diagnostics Market, By End User

• 8.1 Introduction
• 8.2 Veterinary Hospitals & Clinics
• 8.3 Reference Laboratories
• 8.4 In-House Testing
• 8.5 Research Institutes & Universities
• 8.6 Other End Users

9 Global Veterinary Diagnostics Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 IDEXX Laboratories, Inc.
• 11.2 Zoetis Services LLC
• 11.3 Heska Corporation
• 11.4 Thermo Fisher Scientific Inc.
• 11.5 Avante Animal Health
• 11.6 Virbac
• 11.7 Randox Laboratories Ltd.
• 11.8 VCA Animal Hospitals
• 11.9 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 11.10 Antech Diagnostics, Inc.
• 11.11 Agrolabo S.p.A.
• 11.12 Embark Veterinary, Inc.
• 11.13 Esaote SPA
• 11.14 Innovative Diagnostics SAS
• 11.15 FUJIFILM Corporation
• 11.16 Neogen Corporation
• 11.17 Bio-Rad Laboratories, Inc.
• 11.18 INDICAL Bioscience GmbH